NCT06090591 Cardiology Research Dubrava Prospective Registry
| NCT ID | NCT06090591 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Dubrava |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2033-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2023-01-01 with a primary completion date of 2033-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.
Eligibility Criteria
Inclusion Criteria: patients implanted with CIED, or with VTE, or with ACS or with TAVI - Exclusion Criteria: non compliance, not undergoing follow-up at this center \-
Contact & Investigator
Ivana Jurin, M.D.
STUDY CHAIR
Dubrava University Hospital
Frequently Asked Questions
Who can join the NCT06090591 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06090591 currently recruiting?
Yes, NCT06090591 is actively recruiting participants. Contact the research team at kardio@kbd.hr for enrollment information.
Where is the NCT06090591 trial being conducted?
This trial is being conducted at Zagreb, Croatia.
Who is sponsoring the NCT06090591 clinical trial?
NCT06090591 is sponsored by University Hospital Dubrava. The principal investigator is Ivana Jurin, M.D. at Dubrava University Hospital. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.